iHuman CFO reports option and ADS holdings

iHuman Inc. director and Chief Financial Officer Wang Weiwei filed an initial ownership report listing existing equity awards and holdings.

Rhea-AI Filing Summary

iHuman Inc. director and Chief Financial Officer Wang Weiwei filed an initial ownership report listing existing equity awards and holdings. The filing shows stock options over 2,200,000 and 520,000 underlying Class A ordinary shares at an exercise price of $0.0500 per share, plus 200,000 American Depositary Shares held indirectly through the issuer's ESOP platform. Footnotes explain that each ADS represents five Class A ordinary shares and that one option grant from December 15, 2022 vests over four years through December 15, 2026.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider Wang Weiwei

Role Chief Financial Officer

Type	Security	Shares	Price	Value
holding	Options	--	--	--
holding	Options	--	--	--
holding	American Depositary Shares	--	--	--

Holdings After Transaction: Options — 2,720,000 contracts (Direct); American Depositary Shares — 200,000 shares (Indirect, By the issuer's ESOP platform)

Footnotes (2)

1. F1. Each American Depositary Share represents five Class A ordinary shares.
2. F2. These options were granted on December 15, 2022 and vest over a four-year period, with 25% of the options vesting on December 15, 2022, 25% on December 15, 2023, 25% on December 15, 2024, 16.7% on December 15, 2025, and the remaining 8.3% on December 15, 2026.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does iHuman (IH) CFO Wang Weiwei report in this Form 3?

Wang Weiwei reports existing equity holdings, mainly stock options and American Depositary Shares. The filing lists options tied to Class A ordinary shares and ADS held indirectly through the company’s ESOP platform, establishing his baseline ownership as a director and Chief Financial Officer.

How many iHuman (IH) options does Wang Weiwei hold and at what price?

He holds options linked to 2,200,000 and 520,000 Class A ordinary shares, each with a $0.0500 exercise price. These options give the right, but not the obligation, to acquire shares at that fixed price before their respective expiration dates in 2030 and 2032.

What American Depositary Share (ADS) holdings are reported for iHuman (IH)?

The Form 3 shows 200,000 American Depositary Shares held indirectly through the issuer’s ESOP platform. A footnote states each ADS represents five Class A ordinary shares, so the ADS position reflects an economic interest in a larger number of underlying ordinary shares.

How do Wang Weiwei’s iHuman (IH) options vest over time?

One option grant dated December 15, 2022 vests over four years. According to the footnote, 25% vested on December 15, 2022, 25% on December 15, 2023, 25% on December 15, 2024, 16.7% on December 15, 2025, and the remaining 8.3% on December 15, 2026.

Does this iHuman (IH) Form 3 show any share purchases or sales by the CFO?

The Form 3 does not report any share purchases or sales; it only lists existing holdings. All entries are characterized as holdings, with transaction codes and summary data showing no buys, sells, exercises, gifts, or tax-related dispositions recorded in this filing.

What are the expiration dates of Wang Weiwei’s iHuman (IH) option grants?

The reported option positions expire on September 8, 2030 and December 15, 2032. These dates mark the last days on which the options can be exercised at the specified $0.0500 exercise price for the underlying Class A ordinary shares described in the filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/18/2026 - 05:58 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Wang Weiwei

(Last) (First) (Middle)

TOWER 306, NO.86 BEIYUAN ROAD

CHAOYANG DISTRICT

(Street)

BEIJING 100101

(City) (State) (Zip)

CHINA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
iHuman Inc. [ IH ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
American Depositary Shares(1)	200,000	I	By the issuer's ESOP platform

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Options	09/08/2020	09/08/2030	Class A ordinary shares	2,200,000	$0.05	D
Options	(2)	12/15/2032	Class A ordinary shares	520,000	$0.05	D

Explanation of Responses:

1. Each American Depositary Share represents five Class A ordinary shares.

2. These options were granted on December 15, 2022 and vest over a four-year period, with 25% of the options vesting on December 15, 2022, 25% on December 15, 2023, 25% on December 15, 2024, 16.7% on December 15, 2025, and the remaining 8.3% on December 15, 2026.

	/s/ Weiwei Wang	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)